Capricor Therapeutics, Inc. Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 1.27M1.27M1.35M1.90M0.50M4.79M5.52M4.00M2.67M1.67M1.01M0.31M0.24M2.60M25.18M40.00M
Gross Profit 1.27M1.27M1.35M1.90M0.50M4.79M5.52M4.00M2.67M1.67M1.01M0.31M0.24M2.60M25.18M40.00M
Operating items
Research & Development 21.78M25.86M4.14M2.63M5.20M7.79M13.76M16.04M10.77M12.07M5.14M8.50M13.60M21.82M36.45M50.00M
Selling, General & Administrative 12.00M14.21M2.12M1.36M2.21M3.02M4.37M4.93M4.76M4.93M3.60M5.54M7.61M10.43M12.81M14.87M
Other Operating Expenses 0.04M0.04M-0.00M-0.04M-0.01M-0.03M-0.01M-0.11M
Operating Expenses 33.77M40.07M6.25M4.00M7.41M10.80M18.13M20.98M15.53M17.00M8.74M14.00M21.18M32.25M49.26M64.84M
Operating Income -4.90M-2.10M-6.90M-6.02M-12.61M-16.98M-12.86M-15.33M-7.73M-13.69M-20.94M-29.70M-24.08M-42.56M
EBIT -4.90M-2.10M-6.90M-6.02M-12.61M-16.98M-12.86M-15.33M-7.73M-13.69M-20.94M-29.70M-24.08M-42.56M
Non-operating items
Interest & Investment Income 0.77M0.79M0.01M0.03M-0.01M0.00M0.00M0.01M0.04M0.14M0.09M0.03M0.06M0.52M1.73M2.20M
Other Non Operating Income -0.61M-0.34M0.01M0.55M
Non Operating Income -0.10M0.01M0.03M-1.99M-0.20M-0.25M-1.83M15.29M0.14M0.09M0.03M0.92M0.68M1.79M2.10M
Net income details
EBT -4.89M-2.07M-6.97M-6.22M-12.86M-17.31M-13.22M-15.19M-7.64M-13.66M-20.88M-29.18M-22.35M-40.36M
Profit After Tax -33.90M39.93M-4.88M-2.07M-8.89M-6.22M-12.86M-18.81M2.43M-15.19M-7.64M-13.66M-20.02M-29.02M-22.29M-40.47M
Income from Continuing Operations -4.89M-2.07M-6.97M-6.22M-12.86M-17.31M-13.22M-15.19M-7.64M-13.66M-20.88M-29.18M-22.35M-40.36M
Consolidated Net Income -4.89M-2.07M-6.97M-6.22M-12.86M-17.31M-13.22M-15.19M-7.64M-13.66M-20.88M-29.18M-22.35M-40.36M
Income towards Parent Company -4.89M-2.07M-6.97M-6.22M-12.86M-17.31M-13.22M-15.19M-7.64M-13.66M-20.88M-29.18M-22.35M-40.36M
Net Income towards Common Stockholders -4.89M-2.07M-6.97M-6.22M-12.86M-17.31M-13.22M-15.19M-7.64M-13.66M-20.88M-29.18M-22.35M-40.36M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.05M0.07M0.08M0.09M0.09M1.17M1.63M2.14M2.57M3.11M4.25M20.45M24.15M25.24M30.79M45.47M
Shares Outstanding (Diluted Average) 18.55M26.79M29.41M15.57M23.09M24.55M26.78M35.22M
EBITDA -4.90M-2.09M-8.87M-6.22M-12.85M-18.81M2.44M-15.19M-7.65M-13.70M-20.02M-28.91M-22.20M-39.70M